EP0721464A4 - Neuronenregulationsfaktor zur erhöhung der überlebensrate von neuronen - Google Patents

Neuronenregulationsfaktor zur erhöhung der überlebensrate von neuronen

Info

Publication number
EP0721464A4
EP0721464A4 EP94928025A EP94928025A EP0721464A4 EP 0721464 A4 EP0721464 A4 EP 0721464A4 EP 94928025 A EP94928025 A EP 94928025A EP 94928025 A EP94928025 A EP 94928025A EP 0721464 A4 EP0721464 A4 EP 0721464A4
Authority
EP
European Patent Office
Prior art keywords
neuron
promoting
regulatory factor
survival
neuron survival
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94928025A
Other languages
English (en)
French (fr)
Other versions
EP0721464A1 (de
Inventor
Timothy J Cunningham
Forest Haun
Katie L Eagleson
Pat R Levitt
Sarah E Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
START TECHNOLOGY PARTNERSHIP
Original Assignee
START TECHNOLOGY PARTNERSHIP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by START TECHNOLOGY PARTNERSHIP filed Critical START TECHNOLOGY PARTNERSHIP
Publication of EP0721464A1 publication Critical patent/EP0721464A1/de
Publication of EP0721464A4 publication Critical patent/EP0721464A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP94928025A 1993-09-01 1994-08-31 Neuronenregulationsfaktor zur erhöhung der überlebensrate von neuronen Withdrawn EP0721464A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11574893A 1993-09-01 1993-09-01
US115748 1993-09-01
PCT/US1994/010051 WO1995006662A1 (en) 1993-09-01 1994-08-31 Neuron regulatory factor for promoting neuron survival

Publications (2)

Publication Number Publication Date
EP0721464A1 EP0721464A1 (de) 1996-07-17
EP0721464A4 true EP0721464A4 (de) 1998-12-30

Family

ID=22363189

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94928025A Withdrawn EP0721464A4 (de) 1993-09-01 1994-08-31 Neuronenregulationsfaktor zur erhöhung der überlebensrate von neuronen

Country Status (6)

Country Link
US (1) US6262024B1 (de)
EP (1) EP0721464A4 (de)
JP (1) JPH09503386A (de)
AU (1) AU692181B2 (de)
CA (1) CA2170751A1 (de)
WO (1) WO1995006662A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743628B1 (en) 1995-08-28 2004-06-01 Washington University Method of cell culture using neurturin
US5739307A (en) * 1995-08-28 1998-04-14 Washington University Polynucleotide encoding neurturin neurotrophic factor
US6716600B1 (en) 1996-03-14 2004-04-06 Washington University Persephin and related growth factors
US6222022B1 (en) 1996-03-14 2001-04-24 Washington University Persephin and related growth factors
ES2237793T3 (es) 1996-03-14 2005-08-01 Washington University Persefina y factores de crecimiento relacionados.
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
WO1999051736A1 (en) * 1998-04-03 1999-10-14 Mcp Hahnemann University Neuron regulatory factor comprising a small peptide for promoting neuron survival
CN101310772B (zh) * 1999-06-14 2012-02-08 亨利福特保健系统公司 用于诱导神经发生的氧化氮供体
US7655423B2 (en) * 1999-06-14 2010-02-02 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
WO2001092289A1 (en) * 2000-05-31 2001-12-06 Japan Science And Technology Corporation SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1
US7563862B2 (en) * 2001-08-24 2009-07-21 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods for their use in treatment of brain damage
JP4399260B2 (ja) * 2001-08-24 2010-01-13 ニューレン ファーマシューティカルズ リミテッド 神経再生ペプチドおよび脳損傷治療におけるその使用方法
US7608696B2 (en) * 2001-10-26 2009-10-27 Dana-Farber Cancer Institute, Inc. IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
US7528112B2 (en) * 2002-11-15 2009-05-05 Drexel University Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders
US8106019B2 (en) * 2002-11-15 2012-01-31 Philadelphia Health & Education Corporation CHEC-7 a novel sPLA2 inhibitor
JP5026083B2 (ja) * 2003-10-31 2012-09-12 クロンズ ホールディングズ カンパニー リミテッド 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法
WO2011126804A1 (en) 2010-04-09 2011-10-13 Philadelphia Health & Education Corporation Uses of chec peptides to treat neurological and cardiovascular diseases and disorders
CN111460744B (zh) * 2020-04-17 2023-05-23 兰州大学 一种内陆河上游地区的土地利用规划方法及规划系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011026A1 (en) * 1990-12-21 1992-07-09 Case Western Reserve University Neuronal cholinergic differentiation factor
WO1993006116A1 (en) * 1991-09-20 1993-04-01 Syntex-Synergen Neuroscience Joint Venture Glial derived neurotrophic factor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215969A (en) 1989-08-11 1993-06-01 Hahnemann University Dopaminergic neurotrophic factor for treatment of Parkinson's disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011026A1 (en) * 1990-12-21 1992-07-09 Case Western Reserve University Neuronal cholinergic differentiation factor
WO1993006116A1 (en) * 1991-09-20 1993-04-01 Syntex-Synergen Neuroscience Joint Venture Glial derived neurotrophic factor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
R.PATERSON ET AL.: "Alpha- Cardiac Actin Is the Major Sarcojmeric Isoform Expressed in Embryontic Avian Skeletal Muscle", SCIENCE, vol. 224, 1984, pages 1436 - 8, XP002082150 *
See also references of WO9506662A1 *

Also Published As

Publication number Publication date
CA2170751A1 (en) 1995-03-09
AU7721794A (en) 1995-03-22
US6262024B1 (en) 2001-07-17
WO1995006662A1 (en) 1995-03-09
AU692181B2 (en) 1998-06-04
EP0721464A1 (de) 1996-07-17
JPH09503386A (ja) 1997-04-08

Similar Documents

Publication Publication Date Title
EP0721464A4 (de) Neuronenregulationsfaktor zur erhöhung der überlebensrate von neuronen
GB9223558D0 (en) Containers
GB9223028D0 (en) Containers
GB2264088B (en) Trolleys
GB9224572D0 (en) Containers
GB9225701D0 (en) Gantry
GB9204588D0 (en) Containers
GB9215434D0 (en) Containers
GB2269346B (en) Trolleys
GB2269309B (en) Trolleys
EP0561439A3 (en) Ersions
GB2270496B (en) Laminates
GB2264252B (en) Containers
PL54505Y1 (en) Pontoon
GB9221734D0 (en) Transporter
AU120329S (en) Tunic
GB9221358D0 (en) Laminates
GB9220778D0 (en) Laminates
GB9215672D0 (en) Laminates
GB9223213D0 (en) Aviary
AU116522S (en) Aviary
CA70108S (en) Hand truck
GB9221242D0 (en) Emergency parchute stabilizator for helikopters
GB9224104D0 (en) Transport means
HU9200083V0 (en) Meat processing - drawing - vehicle for small butcheries

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960329

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19981113

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990903

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020528